Fennec Banks On EMA’s Seldom-Used PUMA For Sodium Thiosulfate

 
• By Neena Brizmohun

Fennec Pharmaceuticals says that its new formulation of sodium thiosulfate for preventing cisplatin-induced hearing loss in children targets a critical unmet medical need.

Ear of child
The PUMA pathway is designed to incentivize companies to develop medicines exclusively for use in children • Source: Shutterstock

More from Product Reviews

More from Pink Sheet